Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 10, 2009, Pages 1307-1314

  Kalvoda, Jan ^a   Dušková, Jaroslava ^a   Kuběna, Aleš ^b   Povýšil, Ctibor ^a   Kalvodová, Bohdana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Diabetic macular edema; Glykosylated hemoglobin; Internal limiting membrane; Morphometry; Vitrectomy

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DISEASE DURATION; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT DURATION; VITRECTOMY;

AGE FACTORS; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULAR EDEMA; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; VITRECTOMY;

EID: 69549107665     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1100-z     Document Type: Article

References (30)

1. Joussen AM, Naumann GO, Coupland SE, Tamm ER, Kirchhof B, Bornfeld N (2008) Retina and Vitreous. In: Naumann GO, Holbach L, Kruse FE et al (eds) Applied pathology for ophthalmic microsurgeons. Springer, Berlin Heidelberg New York, pp 306-307
2. Matsunaga N, Ozeki H, Hirabayashi Y, Shimada S, Ogura Y (2005) Histopathologic evaluation of the limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 25:311-316, doi: 10.1097/ 00006982-200504000-00010
3. Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloids and the inner limiting membrane. Retina 20:126-133, doi: 10.1097/ 00006982-200003000-00003
4. Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy. Retina 20:54-555
5. Sakamoto T, Miyazaki M, Hisatomi T et al (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423-429, doi: 10.1007/s00417-002-0454-2
6. Doi N, Uemura A, Nakao K, Sakamoto T (2005) Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina 25:742-745, doi: 10.1097/ 00006982-200509000-00009
7. Sonoda KH, Sakamoto T, Enaida H, Miyazaki M, Noda Y, Nakamura T, Ueno A, Yokoyama M, Kubota T, Ishibashi T (2004) Residual vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 111:226-230, doi: 10.1016/j.ophtha.2003.05.034
8. Kumagai K, Furukawa M, Ogino N, Uemura A, Demizu S, Larson E (2004) Vitreous surgery with and without internal limiting membrane peeling for macular hole repair. Retina 24:721-727, doi: 10.1097/ 00006982-200410000-00006
9. Hartley KL, Smiddy W, Flynn H Jr, Murray TG (2008) Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 28:410-419, doi: 10.1097/IAE.0b013e31816102f2
10. Kojima T, Terasaki H, Nomura H, Suzuki T, Mori M, Ito Y, Miyake Y (2003) Vitrectomy for diabetic macular edema: Effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors. Ophthalmic Res 35:192-198, doi: 10.1159/000071170
11. Kuhn F, Kiss G, Mester V, Szijärtó Z, Kovacs B (2004) Vitrectomy with internal limiting membrane removal for clinically significant macular oedema. Graefes Arch Clin Exp Ophthalmol 242:402-408, doi: 10.1007/s00417-004-0876-0
12. Avci R, Kaderli B, Avci B, Simsek S, Baykara M, Kahveci Z, Gelisken O, Yucel AA (2004) Pars plana vitrectomy and removal of the internal limiting in the treatment of chronic macular oedema. Graefes Arch Clin Exp Ophthalmol 242:845-852, doi: 10.1007/s00417-004-0939-2
13. Ikeda T, Sato K, Katano T, Hayashi Y (1999) Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 83:12-14, doi: 10.1136/bjo.83.1.12
14. Kimura T, Kiryu J, Nishiwaki H, Oh H, Suzuma K, Watanabe D, Kurimoto M, Takagi H (2005) Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 25:454-461, doi: 10.1097/00006982-200506000-00010
15. Lewis H, Abrams GW, Blumenkranz MS, Camppo R (1999) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloids traction. Ophthalmology 99:753-759
16. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ (2008) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5-13, doi: 10.1097/ 00006982-200601000-00002
17. Figueroa MS, Contreras I, Noval S (2008) Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 28:420-428, doi: 10.1097/IAE.0b013e318159e7d2
18. Dillinger P, Mester U (2004) Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 242:630-637, doi: 10.1007/s00417-003-0849-8
19. Stefaniotou M, Aspiotis M, Kalogeropoulos C, Christodoulou A, Osykla M, Ioachhim E, Alamanos I, Psilas K (2004) Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 14:137-143
20. Kalvodová B, Záhlava J (2002) Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography. Čes a slov Oftal 58:224-232
21. Pendergast S, Margherio R, Williams G, Cox MJ (1999) Vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 128:317-323, doi: 10.1016/S0002-9394(99)00158-0
22. Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258-260
23. Foss RI (1972) Vitreoretinal juncture: Topographical variations. Invest Ophthalmol 11:801-808
24. Bron AJ, Tripathi RC, Tripathi BJ (1997) Wolff's anatomy of the eye. (The inner limiting membrane). Chapman & Hall, London, p 488
25. La Heij EC, Dieudonné SC, Mooy CM, Diederen RMH, Liem ATA, Zuzlen RJ, Hendrikse F (2005) Immunohistochemical analysis of the internal limiting membrane peeled with indocyanine green. Am J Ophthalmol 140:1123-1125, doi: 10.1016/j.ajo.2005.05.054
26. Sebag J (1991) Age-related differences in the human vitreoretinal interface. Arch Ophthalmol 109:966-971
27. Ducournau D, Ducournau Y (2008) A Closer Look at the ILM. Removal of the ILM induces a cellular response that allows the retina to fight against edema. A Supplement to Retinal Physician, July/August:4-15
28. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes. N Engl J Med 329:977-986, doi: 10.1056/NEJM199309303291401
29. Prospective Diabetes Study Group UK (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. BMJ 317:703-713
30. Do DV, Shah SM, Sung JU, Haller JA, Nguyen QD (2005) Persistent diabetic macular edema is associated with elevated Hemoglobin A1c. Am J Ophthalmol 139:620-623, doi: 10.1016/j.ajo.2004.10.063